8VOI

HADDOCK models of active human alphaM I-domain bound to the the C-terminal domain of the cytokine pleiotrophin

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	4D 13C-HSQC-NOESY-15N-HMQC	1.0 mM The C-terminal Domain of Pleiotrophin, 0.2 mM [U-100% 13C; U-100% 15N; U-80% 2H] active human alphaM I-domain	90% H2O/10% D2O	0.1 M	7	1 atm	298	Bruker AVANCE III HD 850
2	3D HNCACB	0.3 mM [U-100% 13C; U-100% 15N] active human alphaM I-domain	90% H2O/10% D2O	0.1 M	7	1 atm	298	Bruker AVANCE III HD 850
3	3D HN(COCA)CB	0.3 mM [U-100% 13C; U-100% 15N] active human alphaM I-domain	90% H2O/10% D2O	0.1 M	7	1 atm	298	Bruker AVANCE III HD 850
4	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] The C-terminal Domain of Pleiotrophin	90% H2O/10% D2O	0.1 M	7	1 atm	298	Bruker AVANCE III HD 850
5	3D CBCA(CO)NH	1.0 mM [U-100% 13C; U-100% 15N] The C-terminal Domain of Pleiotrophin	90% H2O/10% D2O	0.1 M	7	1 atm	298	Bruker AVANCE III HD 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	850

NMR Refinement
Method	Details	Software
simulated annealing	The Integrin alpha-M starting structure is 1IDO. The Pleiotrophin starting structure is 2N6F.	HADDOCK

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	NMRViewJ		Bruce Johnson
2	structure calculation	HADDOCK		Bonvin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.